Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Catabolic and anabolic actions of parathyroid hormone on the skeleton.

Silva BC, Costa AG, Cusano NE, Kousteni S, Bilezikian JP.

J Endocrinol Invest. 2011 Nov;34(10):801-10. doi: 10.3275/7925. Epub 2011 Sep 23. Review.

2.

Parathyroid hormone: anabolic and catabolic actions on the skeleton.

Silva BC, Bilezikian JP.

Curr Opin Pharmacol. 2015 Jun;22:41-50. doi: 10.1016/j.coph.2015.03.005. Epub 2015 Apr 5. Review.

3.

Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH.

Saini V, Marengi DA, Barry KJ, Fulzele KS, Heiden E, Liu X, Dedic C, Maeda A, Lotinun S, Baron R, Pajevic PD.

J Biol Chem. 2013 Jul 12;288(28):20122-34. doi: 10.1074/jbc.M112.441360. Epub 2013 Jun 2.

4.
5.

[Parathyroid and bone. Effect of parathyroid hormone on bone quality].

Ito M.

Clin Calcium. 2007 Dec;17(12):1858-64. Review. Japanese.

PMID:
18057661
6.

A theoretical model for simulating effect of parathyroid hormone on bone metabolism at cellular level.

Wang Y, Qin QH, Kalyanasundaram S.

Mol Cell Biomech. 2009 Jun;6(2):101-12.

PMID:
19496258
7.

Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.

Rhee Y, Lee EY, Lezcano V, Ronda AC, Condon KW, Allen MR, Plotkin LI, Bellido T.

J Biol Chem. 2013 Oct 11;288(41):29809-20. doi: 10.1074/jbc.M113.485938. Epub 2013 Aug 20.

8.

Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL.

Pierroz DD, Bonnet N, Baldock PA, Ominsky MS, Stolina M, Kostenuik PJ, Ferrari SL.

J Biol Chem. 2010 Sep 3;285(36):28164-73. doi: 10.1074/jbc.M110.101964. Epub 2010 Jun 17.

9.

The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics.

Lombardi G, Di Somma C, Rubino M, Faggiano A, Vuolo L, Guerra E, Contaldi P, Savastano S, Colao A.

J Endocrinol Invest. 2011 Jul;34(7 Suppl):18-22. Review.

PMID:
21985975
10.

Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice.

Machado do Reis L, Kessler CB, Adams DJ, Lorenzo J, Jorgetti V, Delany AM.

Bone. 2008 Aug;43(2):264-73. doi: 10.1016/j.bone.2008.03.024. Epub 2008 Apr 13.

11.

Mice lacking bone sialoprotein (BSP) lose bone after ovariectomy and display skeletal site-specific response to intermittent PTH treatment.

Wade-Gueye NM, Boudiffa M, Laroche N, Vanden-Bossche A, Fournier C, Aubin JE, Vico L, Lafage-Proust MH, Malaval L.

Endocrinology. 2010 Nov;151(11):5103-13. doi: 10.1210/en.2010-0091. Epub 2010 Sep 15.

PMID:
20844009
12.

[Parathyroid and bone. The mechanism of anabolic function of parathyroid hormone on bone].

Ogata N, Kawaguchi H.

Clin Calcium. 2007 Dec;17(12):1843-9. Review. Japanese.

PMID:
18057659
13.
14.

Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans.

Aslan D, Andersen MD, Gede LB, de Franca TK, Jørgensen SR, Schwarz P, Jørgensen NR.

Scand J Clin Lab Invest. 2012 Feb;72(1):14-22. doi: 10.3109/00365513.2011.624631. Epub 2011 Nov 16. Review.

PMID:
22085136
15.

Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone.

Goltzman D.

Arch Biochem Biophys. 2008 May 15;473(2):218-24. doi: 10.1016/j.abb.2008.03.003. Epub 2008 Mar 10. Review.

PMID:
18358824
16.

Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation.

Ma YL, Cain RL, Halladay DL, Yang X, Zeng Q, Miles RR, Chandrasekhar S, Martin TJ, Onyia JE.

Endocrinology. 2001 Sep;142(9):4047-54.

PMID:
11517184
17.

The cellular and clinical parameters of anabolic therapy for osteoporosis.

Rosen CJ.

Crit Rev Eukaryot Gene Expr. 2003;13(1):25-38. Review.

PMID:
12839095
18.

Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34).

Wang L, Quarles LD, Spurney RF.

J Bone Miner Res. 2004 Oct;19(10):1661-70. Epub 2004 Jul 14.

19.

Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice.

Feng Y, Zhou M, Zhang Q, Liu H, Xu Y, Shu L, Zhang J, Miao D, Ren Y.

Br J Nutr. 2015 Mar 28;113(6):909-22. doi: 10.1017/S0007114514004309. Epub 2015 Mar 6.

20.

Mechanisms underlying catabolic and anabolic functions of parathyroid hormone on bone by combination of culture systems of mouse cells.

Shinoda Y, Kawaguchi H, Higashikawa A, Hirata M, Miura T, Saito T, Nakamura K, Chung UI, Ogata N.

J Cell Biochem. 2010 Mar 1;109(4):755-63. doi: 10.1002/jcb.22454.

PMID:
20058231

Supplemental Content

Support Center